Provided by Tiger Trade Technology Pte. Ltd.

LIVZON PHARMA

21.940
-0.780-3.43%
Volume:623.38K
Turnover:13.61M
Market Cap:19.48B
PE:9.67
High:23.180
Open:23.180
Low:21.520
Close:22.720
52wk High:33.311
52wk Low:19.800
Shares:888.00M
HK Float Shares:300.00M
Volume Ratio:0.21
T/O Rate:0.21%
Dividend:1.64
Dividend Rate:7.49%
EPS(LYR):2.270
ROE:13.42%
ROA:5.93%
PB:1.25
PE(LYR):9.67
PS:1.55

Loading ...

LIVZON PHARMA's Recombinant Human Follitropin Injection Receives Marketing Authorization

Stock News
·
Jun 01

Livzon Pharma’s Lecankitug Injection NDA for Ankylosing Spondylitis Accepted by China NMPA

Bulletin Express
·
Jun 01

LIVZON PHARMA's Application for New Antibody Drug Receives Regulatory Acceptance

Stock News
·
Jun 01

LIVZON PHARMA Appoints Ran Yongmei as Employee Representative Director

Stock News
·
May 29

Livzon Pharma Announces Updated Board Structure and Committee Line-up

Bulletin Express
·
May 29

LIVZON PHARMA Announces Final Dividend Payout Scheduled for July 13

Stock News
·
May 29

LIVZON PHARMA Appoints Liu Daping as President

Stock News
·
May 29

Livzon Pharmaceutical Gains Strong Shareholder Backing at 2025 AGM; Confirms RMB14.30 Cash Dividend per 10 Shares

Bulletin Express
·
May 29

Insights from Day One of the Shenzhen Stock Exchange Global Investor Conference: Market Valuations Deemed Reasonable, Steady Inflows of Foreign Capital, and Chinese Assets Showcase Distinct 'Safety Premium'

Deep News
·
May 28

Livzon Pharma Maintains 887.91 million Authorised Shares; Public Float Meets HKEX Requirement in April 2026

Bulletin Express
·
May 06

Domestic Semaglutide's First Approval Faces Delays as Companies Cite Data Exclusivity Period Following Patent Expiry

Stock News
·
Apr 25

Livzon Pharma Publishes Revised Proxy Form for 2025 AGM; Original Version Void

Bulletin Express
·
Apr 24

Livzon Pharma Releases 2025 Annual Report and AGM Documentation Online

Bulletin Express
·
Apr 23

Livzon Pharma Announces FY2025 Final Dividend of RMB14.3 per 10 Shares

Bulletin Express
·
Apr 23

Livzon Pharma to Seek H-Share Buyback Mandate at 29 May 2026 Class Meeting

Bulletin Express
·
Apr 23

Livzon Pharma Publishes 2025 Annual Report and AGM Materials Online; Shareholders Asked to Confirm E-Communication Preferences

Bulletin Express
·
Apr 23

LIVZON PHARMA (01513) to Distribute Final Dividend of RMB 14.3 per 10 Shares on July 13

Stock News
·
Apr 23

LIVZON PHARMA Reports Q1 Net Profit of 577 Million Yuan, Down 9.39%

Stock News
·
Apr 23

Livzon Pharma Q1 2026: Revenue and Profit Retreat While Cash Generation Improves

Bulletin Express
·
Apr 23

Livzon Pharma proposes Liu Daping as Executive Director and Kang Li as Independent Director

Bulletin Express
·
Apr 23